Zydus and Lupin Partner to Co-Market Semaglutide Injection in India, Expanding Access to Diabetes and Weight Management Therapies
Zydus Lifesciences Limited has entered into a licensing and supply agreement with Lupin Limited to co-market an innovative Semaglutide Injection in India, marking a significant step toward improving access to advanced treatments for diabetes and weight management. The partnership brings together Zydus’ product development expertise and Lupin’s strong distribution network, with a shared focus on … Read more